Patentability issues surrounding antivirals

The development of antivirals as in vivo therapeutics has resulted in a huge upsurge in the number of granted US patents. However, patentability concerns have always surrounded antivirals. Even though government seizure of a patent is a worst-cast scenario, it remains a distinct possibility.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature biotechnology 2007-12, Vol.25 (12), p.1403-1404
Hauptverfasser:	Lu, Deborah L, Collison, Angela M, Kowalski, Thomas J
Format:	Artikel
Sprache:	eng
Schlagworte:	Agriculture Antiviral Agents Antiviral drugs Bioinformatics Biological and medical sciences Biomedical and Life Sciences Biomedical Engineering/Biotechnology Biomedicine Biotechnology Drug Design Drug Industry - legislation & jurisprudence Fundamental and applied biological sciences. Psychology Legislation. General informations Life Sciences Litigation Ownership - legislation & jurisprudence Patents as Topic - legislation & jurisprudence Pharmaceutical industry United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The development of antivirals as in vivo therapeutics has resulted in a huge upsurge in the number of granted US patents. However, patentability concerns have always surrounded antivirals. Even though government seizure of a patent is a worst-cast scenario, it remains a distinct possibility.
ISSN:	1087-0156 1546-1696
DOI:	10.1038/nbt1207-1403